Cardio Diagnostics Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cardio Diagnostics Holdings, Inc. on February 21, 2025. The report serves as a current disclosure regarding the commencement of the use of a new Investor Presentation by senior management for meetings with existing and prospective investors.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural disclosure regarding investor communications and does not contain a financial statement or performance update.
Material Changes
There are no material changes to financial performance or operations reported in this filing. The primary change is the authorization for management to utilize the materials contained in Exhibit 99.1 (the February 2025 Investor Presentation) for investor relations activities effective February 21, 2025.
Guidance, Outlook, and Risks
The filing incorporates an Investor Presentation by reference but does not summarize its contents, guidance, or outlook within the text of the 8-K. The document includes a standard disclaimer stating that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the contents of the February 2025 Investor Presentation (Exhibit 99.1) available on the company website at www.cardiodiagnosticsinc.com for actual business updates.
- Note that the information in this 8-K is not legally "filed" under Section 18 of the Exchange Act, limiting its liability protections compared to standard financial reports.
- Confirm the trading symbols CDIO (Common Stock) and CDIOW (Warrants) on The Nasdaq Stock Market LLC.